Tumor Grade in Molecularly Defined Endometrial Carcinoma: Prognostic Implications of the ESGO-ESTRO-ESP 2025 Guidelines.
Saved in:
| Title: | Tumor Grade in Molecularly Defined Endometrial Carcinoma: Prognostic Implications of the ESGO-ESTRO-ESP 2025 Guidelines. |
|---|---|
| Authors: | Loukovaara M; Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki.; Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki., Pasanen A; Department of Pathology, Helsinki University Hospital and Research Program in Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Bützow R; Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki.; Department of Pathology, Helsinki University Hospital and Research Program in Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland. |
| Source: | International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists [Int J Gynecol Pathol] 2026 Jul 02. Date of Electronic Publication: 2026 Jul 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8214845 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7151 (Electronic) Linking ISSN: 02771691 NLM ISO Abbreviation: Int J Gynecol Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1538-7151 |
|---|---|
| DOI: | 10.1097/PGP.0000000000001202 |
